Derivative exercise or conversion — not an open-market buy.
Traded Feb 18, 2026 · Filed Feb 19, 2026
CNO Financial's General Counsel sold $1.46M of CNO Financial shares. It was planned long ago, so it says very little.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
open market sale
Code S — open-market or private sale
~$1,455,141
Shares × reported transaction price
13 days after results of Feb 5, 2026, 71 days before results of Apr 30, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Footnote references a pre-arranged trading plan (Rule 10b5-1)
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | +1.1% | +0.7% | +0.5% |
| 30 days | −4.8% | −4.3% | −0.5% |
| 90 days | +10.9% | +8.3% | +2.6% |
| 180 days | +28.0% | +12.1% | +15.9% |
Past results only. Not a forecast.
Derivative exercise or conversion — not an open-market buy.
Officer sold ~$1.02M of CNO Financial Group
Scheduled in advanceDerivative exercise or conversion — not an open-market buy.